Michelle Kasprzak

Michelle Kasprzak, MSHS, serves as the Director of Global Pharmacovigilance & Patient Safety at Sobi - Swedish Orphan Biovitrum AB since April 2021, following a similar role at Dova Pharmaceuticals. Prior experience includes leadership positions in product safety and pharmacovigilance at Merz North America, GSK, and other prominent organizations, demonstrating a robust background in evaluating individual case safety reports, ensuring compliance with regulatory requirements, and establishing product safety departments. Educational qualifications include a Master of Science in Health Science, specializing in Regulatory Affairs from The George Washington University, and a Bachelor's degree in Zoology/Animal Sciences from North Carolina State University.